Umbrella Study for Single Patient Treatments in Oncology
NCT06285500 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-12-16
Summary
The purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.
Conditions
Interventions
- OTHER
-
Patient-specific treatments
Treatment will be decided specifically for the patient based on biomarker test results.
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Principal Investigators
-
Amit Oza, Dr. · University Health Network, Toronto
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-01
- Primary Completion
- 2027-02-01
- Completion
- 2029-02-01
Countries
- Canada
Study Locations
More Related Trials
-
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
NCT07101705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer
NCT00582985 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
NCT02298387 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
NCT01723020 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06022029 ·Status: RECRUITING ·Phase: PHASE1
-
Study of DF6215 in Patients With Advanced Solid Tumors
NCT06108479 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors
NCT00605618 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
NCT07165067 ·Status: RECRUITING ·Phase: PHASE1
-
Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy
NCT06391775 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
NCT05266612 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
NCT05028478 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
NCT02030067 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
NCT06059508 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
NCT05389462 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
NCT06005740 ·Status: RECRUITING ·Phase: PHASE1
-
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
NCT04975958 ·Status: COMPLETED ·Phase: PHASE1
-
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.
NCT06144723 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)
NCT01566279 ·Status: COMPLETED ·Phase: NA
-
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
NCT02108652 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
NCT01608867 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
NCT06417554 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Samalizumab in Patients With Advanced Cancer
NCT02987504 ·Status: TERMINATED ·Phase: PHASE1
-
PRO1107 in Patients With Advanced Solid Tumors
NCT06171789 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
NCT04305249 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
NCT07145255 ·Status: RECRUITING ·Phase: PHASE1/PHASE2